The global vasculitis drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Vasculitis is an inflammation of the blood vessels that affect arteries, veins and capillaries. Additionally, it happens due to an infection, a medicine, or another disease and symptoms such as fatigue, weakness, weight loss, muscle pain, congestive heart failure, malaise, and others. The major factor for the growth of the market is the increasing prevalence of chronic disease across the globe. Autoimmune disorders, trauma, and infections are some instances of potential triggers of inflammation in the blood vessels. Therefore, the rising prevalence of these conditions is accelerating the growth of the market.
To Request a Sample of our Report on Vasculitis Drug Market: https://www.omrglobal.com/request-sample/vasculitis-drug-market
Some major players operating in the market include GlaxoSmithKline plc, F. Hoffmann-La Roche AG, and Novartis International AG, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2021, ChemoCentryx Inc. announced the approval of avacopan (TAVNEOS), an orally administered selective complement 5a receptor inhibitor from the US Food & Drug Administration (FDA). Avacopan is used as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drug Class
- By Disease Type
- By End-User
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- GlaxoSmithKline plc, F. Hoffmann-La Roche AG, and Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Vasculitis Drug Market is Available @ https://www.omrglobal.com/industry-reports/vasculitis-drug-market
Global Vasculitis Drug Market Report by Segment
By Drug Class
- Corticosteroids
- Immunosuppressants
- Biologics
By Disease Type
- Small Vessel
- Large Vessel
- Medium Vessel Vasculitis
By End-User
- Hospitals
- Medical Clinics
- Others
Global Vasculitis Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
